Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 11951-12000 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04842617
Phase III Study :SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative
PHASE3Active, not recruiting
5,274 participants
Started: Apr 30, 2021 · Completed: Oct 31, 2031
1 condition1 sponsor1 location
NCT04470934
"SeQuent® SCB All Comers Post Market Clinical Follow-up (PMCF)"
N/AActive, not recruiting
1,302 participants
Started: Apr 30, 2021 · Completed: Mar 31, 2027
2 conditions1 sponsor1 location
NCT04863885
Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients
PHASE1/PHASE2Active, not recruiting
46 participants
Started: Apr 30, 2021 · Completed: Oct 31, 2027
1 condition3 sponsors1 location
NCT04833114
Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL)
PHASE3Active, not recruiting
306 participants
Started: Apr 30, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors64 locations
NCT04872595
A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
PHASE2Active, not recruiting
59 participants
Started: Apr 30, 2021 · Completed: Apr 30, 2026
3 conditions1 sponsor1 location
NCT03866499
A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients
PHASE3Active, not recruiting
369 participants
Started: Apr 30, 2021 · Completed: Dec 30, 2025
1 condition1 sponsor3 locations
NCT04712981
Adapting the HOPE Online Support Intervention to Increase Uptake of Medications for Opioid Use Disorder
NAActive, not recruiting
640 participants
Started: Apr 29, 2021 · Completed: Oct 31, 2025
1 condition3 sponsors1 location
NCT04336397
Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People
NAActive, not recruiting
1,447 participants
Started: Apr 29, 2021 · Completed: Sep 15, 2024
1 condition2 sponsors1 location
NCT04895943
Bariatric Endoscopy and NAFLD
N/AActive, not recruiting
60 participants
Started: Apr 29, 2021 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT04462328
Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
PHASE1Active, not recruiting
25 participants
Started: Apr 29, 2021 · Completed: Oct 31, 2027
1 condition2 sponsors2 locations
NCT05092776
Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
PHASE2Active, not recruiting
84 participants
Started: Apr 29, 2021 · Completed: Oct 30, 2025
2 conditions9 sponsors14 locations
NCT04704830
R21/Matrix-M in African Children Against Clinical Malaria
PHASE3Active, not recruiting
4,800 participants
Started: Apr 29, 2021 · Completed: Sep 30, 2027
1 condition7 sponsors1 location
NCT05166863
Physical Performance Testing and Frailty in Prediction of Early Postoperative Course After Cardiac Surgery
N/AActive, not recruiting
200 participants
Started: Apr 29, 2021 · Completed: Dec 30, 2024
4 conditions2 sponsors1 location
NCT04739059
Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks
PHASE3Active, not recruiting
171 participants
Started: Apr 29, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor44 locations
NCT05242731
Telemonitoring and Connected Care Applied to Multiple Sclerose
NAActive, not recruiting
208 participants
Started: Apr 29, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT04974567
Tear Based Sample Collection Breast Cancer Detection
N/AActive, not recruiting
50 participants
Started: Apr 28, 2021 · Completed: Sep 15, 2025
3 conditions2 sponsors1 location
NCT04754945
Isatuximab As Upfront Therapy for the Treatment of High Risk AL Amyloidosis
PHASE1Active, not recruiting
11 participants
Started: Apr 28, 2021 · Completed: Jul 24, 2026
1 condition3 sponsors6 locations
NCT05004285
Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis
PHASE3Active, not recruiting
398 participants
Started: Apr 28, 2021 · Completed: Jun 1, 2025
1 condition1 sponsor5 locations
NCT05902429
Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients
PHASE4Active, not recruiting
10 participants
Started: Apr 28, 2021 · Completed: Aug 31, 2024
1 condition2 sponsors1 location
NCT04783506
Characterizing Inflammatory Profiles and Suicidal Behavior in Adolescents
N/AActive, not recruiting
225 participants
Started: Apr 28, 2021 · Completed: Nov 15, 2025
1 condition2 sponsors1 location
NCT04688788
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
PHASE3Active, not recruiting
600 participants
Started: Apr 28, 2021 · Completed: May 5, 2029
3 conditions17 sponsors11 locations
NCT04251715
mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma
PHASE2Active, not recruiting
5 participants
Started: Apr 28, 2021 · Completed: Nov 30, 2025
6 conditions2 sponsors1 location
NCT04723264
The Development of Eating Behavior in Infancy: Associations With Behavior, Diet, and Growth at School Age
NAActive, not recruiting
400 participants
Started: Apr 28, 2021 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT04658472
Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
PHASE2Active, not recruiting
110 participants
Started: Apr 28, 2021 · Completed: Sep 30, 2025
1 condition1 sponsor32 locations
NCT04419766
Evaluation of IR3535 as a Spatial Repellent for Malaria Control.
NAActive, not recruiting
166 participants
Started: Apr 28, 2021 · Completed: Oct 31, 2025
1 condition3 sponsors1 location
NCT04641819
Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients
PHASE4Active, not recruiting
1,127 participants
Started: Apr 27, 2021 · Completed: Jun 30, 2024
2 conditions3 sponsors10 locations
NCT04735653
The Support, Educate, Empower (SEE) Program
NAActive, not recruiting
236 participants
Started: Apr 27, 2021 · Completed: Aug 30, 2025
1 condition2 sponsors2 locations
NCT04850846
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
PHASE2Active, not recruiting
60 participants
Started: Apr 27, 2021 · Completed: Jul 31, 2027
2 conditions2 sponsors7 locations
NCT04756726
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
PHASE1Active, not recruiting
224 participants
Started: Apr 27, 2021 · Completed: Mar 31, 2026
2 conditions1 sponsor13 locations
NCT03275974
Glutamine PET Imaging Colorectal Cancer
PHASE1Active, not recruiting
6 participants
Started: Apr 27, 2021 · Completed: Feb 2, 2027
4 conditions1 sponsor1 location
NCT04839081
Neuropathic Hand Pain in Rheumatoid Arthritis
N/AActive, not recruiting
300 participants
Started: Apr 26, 2021 · Completed: Jun 15, 2026
1 condition1 sponsor1 location
NCT04610944
Changing Talk Online Training (CHATO) National Trial
NAActive, not recruiting
5,043 participants
Started: Apr 26, 2021 · Completed: May 31, 2026
3 conditions2 sponsors1 location
NCT04874688
Child Health, Agriculture and Integrated Nutrition
NAActive, not recruiting
192 participants
Started: Apr 26, 2021 · Completed: Dec 19, 2025
1 condition4 sponsors1 location
NCT04780516
Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care
N/AActive, not recruiting
141 participants
Started: Apr 26, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor11 locations
NCT04784715
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
PHASE3Active, not recruiting
1,157 participants
Started: Apr 26, 2021 · Completed: Dec 30, 2029
1 condition2 sponsors283 locations
NCT04770896
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
PHASE3Active, not recruiting
557 participants
Started: Apr 26, 2021 · Completed: Oct 17, 2025
1 condition1 sponsor123 locations
NCT04732845
Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies
PHASE1Active, not recruiting
18 participants
Started: Apr 26, 2021 · Completed: Dec 1, 2039
3 conditions1 sponsor1 location
NCT03601806
Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection
PHASE2Active, not recruiting
26 participants
Started: Apr 26, 2021 · Completed: Jan 2, 2026
2 conditions8 sponsors3 locations
NCT04381299
Will Autologous Platelet Rich Plasma Able To Restore Ovarian Function?
N/AActive, not recruiting
35 participants
Started: Apr 25, 2021 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT05518396
Prospective Validation of the CoDE-HF Algorithm for the Diagnosis of Acute Heart Failure
N/AActive, not recruiting
3,808 participants
Started: Apr 25, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT04825743
A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI
PHASE3Active, not recruiting
2,463 participants
Started: Apr 24, 2021 · Completed: May 13, 2026
1 condition1 sponsor45 locations
NCT04448002
AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma
NAActive, not recruiting
320 participants
Started: Apr 23, 2021 · Completed: Mar 31, 2026
1 condition2 sponsors2 locations
NCT05143853
HORizontal Instability AC Joint Study: A Prospective Randomised Clinical Trial
NAActive, not recruiting
70 participants
Started: Apr 23, 2021 · Completed: Sep 1, 2024
1 condition1 sponsor1 location
NCT05441956
TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE1Active, not recruiting
198 participants
Started: Apr 23, 2021 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT04795752
Prospective, Randomized, Masked, Controlled Trial To Evaluate The Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)
NAActive, not recruiting
350 participants
Started: Apr 23, 2021 · Completed: May 22, 2024
2 conditions1 sponsor14 locations
NCT04959890
Methodology Study of Retroviral Insertion Site Analysis in Strimvelis Gene Therapy
N/AActive, not recruiting
15 participants
Started: Apr 23, 2021 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT04818333
A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer
PHASE1/PHASE2Active, not recruiting
157 participants
Started: Apr 23, 2021 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04806893
Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction
PHASE3Active, not recruiting
900 participants
Started: Apr 22, 2021 · Completed: Feb 28, 2024
4 conditions2 sponsors6 locations
NCT04872439
Novel Antineuronal Antibodies in Gastrointestinal Motility Disorders
N/AActive, not recruiting
300 participants
Started: Apr 22, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04888845
Refinement of Suicide Risk Management Intervention
NAActive, not recruiting
120 participants
Started: Apr 22, 2021 · Completed: Jul 30, 2026
4 conditions2 sponsors2 locations